85.96
price down icon1.29%   -1.12
pre-market  Pre-market:  86.27   0.31   +0.36%
loading
Vaxcyte Inc stock is traded at $85.96, with a volume of 1.68M. It is down -1.29% in the last 24 hours and down -25.58% over the past month. Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
See More
Previous Close:
$87.08
Open:
$86.86
24h Volume:
1.68M
Relative Volume:
1.50
Market Cap:
$10.73B
Revenue:
-
Net Income/Loss:
$-507.65M
P/E Ratio:
-22.18
EPS:
-3.876
Net Cash Flow:
$-616.24M
1W Performance:
-11.04%
1M Performance:
-25.58%
6M Performance:
+13.21%
1Y Performance:
+67.20%
1-Day Range:
Value
$85.18
$88.06
1-Week Range:
Value
$84.52
$98.17
52-Week Range:
Value
$48.24
$121.06

Vaxcyte Inc Stock (PCVX) Company Profile

Name
Name
Vaxcyte Inc
Name
Phone
650-837-0111
Name
Address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Name
Employee
254
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
PCVX's Discussions on Twitter

Compare PCVX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
PCVX 85.96 10.73B 0 -507.65M -616.24M -3.876
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-07-23 Initiated Mizuho Buy
Apr-18-23 Initiated TD Cowen Outperform
Jan-03-23 Reiterated Needham Buy
Dec-15-22 Initiated Guggenheim Buy
Nov-17-22 Initiated BTIG Research Buy
Dec-29-21 Resumed Jefferies Buy
Jun-24-21 Resumed Jefferies Buy
Jul-07-20 Initiated BofA Securities Buy
Jul-07-20 Initiated Cantor Fitzgerald Overweight
Jul-07-20 Initiated Needham Buy
View All

Vaxcyte Inc Stock (PCVX) Latest News

pulisher
05:18 AM

Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Segall Bryant & Hamill LLC - MarketBeat

05:18 AM
pulisher
03:13 AM

Principal Financial Group Inc. Purchases 34,287 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

03:13 AM
pulisher
Nov 20, 2024

Jennison Associates LLC Decreases Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Vaxcyte, Inc. (NASDAQ:PCVX) is First Turn Management LLC's 5th Largest Position - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Victory Capital Management Inc. Has $29.14 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Curi RMB Capital LLC Purchases New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Los Angeles Capital Management LLC Takes $1.02 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Vaxcyte (NASDAQ:PCVX) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

RA Capital Management, L.P. Increases Stake in Vaxcyte Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition of Vaxcyte Inc Shares - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Long Term Trading Analysis for (PCVX) - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 13, 2024

Vaxcyte Enters Oversold Territory (PCVX) - Nasdaq

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC Adjusts Stake in Vaxcyte Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Vaxcyte provides regulatory updates on VAX-31 programs - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

FDA advances Vaxcyte's pneumococcal vaccine VAX-31 By Investing.com - Investing.com Canada

Nov 12, 2024
pulisher
Nov 12, 2024

FDA advances Vaxcyte's pneumococcal vaccine VAX-31 - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - The Bakersfield Californian

Nov 12, 2024
pulisher
Nov 12, 2024

Vaxcyte's VAX-31 Vaccine Secures FDA Breakthrough Status, Targets 95% Disease Coverage | PCVX Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

WCM Investment Management LLC Has $15.94 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Lisanti Capital Growth LLC Purchases 13,175 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Cantor Fitzgerald Increases Earnings Estimates for Vaxcyte - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

TimesSquare Capital Management LLC Buys New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $245,803.74 in Stock - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Vaxcyte CEO Grant Pickering sells $245,796 in company stock - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

Vaxcyte CEO Grant Pickering sells $245,796 in company stock By Investing.com - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

FY2024 EPS Estimates for Vaxcyte Raised by Leerink Partnrs - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Vaxcyte's (PCVX) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Vaxcyte's (PCVX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Vaxcyte stock target lifted as analyst sees VAX-31 leading in clinical advancement - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

Leerink Partners reaffirms Outperform on Vaxcyte stock with bullish pipeline outlook - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus.com

Nov 06, 2024
pulisher
Nov 05, 2024

Vaxcyte Reports Progress and Strengthens Financial Position - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

Vaxcyte Inc (PCVX) Reports Q3 2024 Net Loss of $103.1 Million Am - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 05, 2024
pulisher
Nov 05, 2024

Vaxcyte's VAX-31 Vaccine Shows Promise in Phase 1/2, Plans Phase 3 Amid $3.3B Cash Position | PCVX Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 04, 2024

Vaxcyte, Inc. (NASDAQ:PCVX) COO Jim Wassil Sells 8,000 Shares - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Vaxcyte CEO Grant Pickering sells shares worth $1.6 million By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Vaxcyte COO Jim Wassil sells $854k in stock - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Vaxcyte CEO Grant Pickering sells shares worth $1.6 million - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Vaxcyte COO Jim Wassil sells $854k in stock By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 03, 2024

Harbor Capital Advisors Inc. Has $7.39 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 03, 2024
pulisher
Nov 01, 2024

Should You Consider Investing in Vaxcyte (PCVX)? - Insider Monkey

Nov 01, 2024
pulisher
Oct 30, 2024

Raymond James & Associates Buys 11,798 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Vaxcyte’s stock flat as biotech preps to complete $1.42 billion stock offering - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Vaxcyte (NASDAQ:PCVX) Trading Down 5.9%Time to Sell? - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

China Universal Asset Management Co. Ltd. Grows Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Oct 29, 2024
pulisher
Oct 27, 2024

Novo Holdings A S Has $85.70 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Oct 27, 2024

Vaxcyte Inc Stock (PCVX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Cap:     |  Volume (24h):